Dr. Seth assesses the bleeding risk of Botox treatments in patients who take blood thinners

“We're not saying a blanket stop for all patients, but I think we do need to be taking each patient as an individual in terms of their backgrounds,” says Jai Seth, MD.

In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Jai Seth, MD. He discusses onabotulinumtoxinA injection programs as a treatment for urinary incontinence and the bleeding risk associated with these injections for patients who also take blood thinners. Seth is a consultant urological surgeon at St. George’s University hospital, London, UK.

Related Videos
Ricardo M. de Oliveira Soares, MD, answers a question during a Zoom video interview
Patient predictors of postprostatectomy incontinence | Image credit: © jakkapan - stock.adobe.com
Ricardo M. de Oliveira Soares, MD, answers a question during a Zoom video interview
Dr. Woodburn in an interview with Urology Times
Dean Elterman, MD, MSc, FRCSC, in an interview with Urology Times
Anjali Kapur, MD, looks at the camera while answering a question
Anjali Kapur, MD, answers a question about a recent study regarding third-line treatments for OAB
jakkapan - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.